From the GIC Winter 2008 Newsletter pdf format of fybwinter2008.pdf

Photocopy your drug formulary and give it to each of your doctors: Your formulary lists the drugs that are available at lower co-payments. Give a copy of the formulary to each doctor you see. Discuss with your doctor whether the drugs with lower co-payments are appropriate for you.

Some GIC plans continuously update their formulary, while others update throughout the year and then produce a new formulary in January. Express Scripts, the pharmacy benefit manager for Commonwealth Indemnity Plan members, mails its new formulary to members at the beginning of December; it's also available on their website. Other GIC health plans post the formularies on their websites, or members can call and have a formulary mailed to them.

Mail-Order: If you are taking prescription drugs for a long-term condition such as asthma, high blood pressure, allergies, or high cholesterol, switching your prescription from a retail pharmacy to mail-order will save you money - up to one co-pay every three months. For example, if you are in Navigator by Tufts Health Plan, you would pay $20 each month for a tier 2 drug from a local pharmacy, but only pay $40 every three months if you use mail-order. By using mail order, you would save $80 per year per tier 2 drug. Plus, you'll have the convenience of home delivery.

It's easy to get started on mail-order. Have your doctor write a prescription for up to a 90-day supply of your medication, plus refills for up to one year if appropriate. Complete a mail order form, available from your prescription drug plan, and send it with your prescription and co-pay to the address listed.


This information provided by the Group Insurance Commission .

Recommended Content

People also viewed...

You recently viewed...

Personalization is OFF. Your personal browsing history at Mass.gov is not visible because your personalization is turned off. To view your history, turn your personalization on.

Learn more on our .

*Recommendations are based on site visitor traffic patterns and are not endorsements of that content.